These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4678048)

  • 1. The national program for cancer chemotherapy.
    Zubrod CG
    JAMA; 1972 Nov; 222(9):1161-2. PubMed ID: 4678048
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of the report of the 1966 Cancer Chemotherapy Collaborative Program Review Committee.
    Richardson AP
    Cancer Treat Rep; 1984 Jan; 68(1):340-1. PubMed ID: 6692434
    [No Abstract]   [Full Text] [Related]  

  • 4. Origins and development of chemotherapy research at the National Cancer Institute.
    Zubrod CG
    Cancer Treat Rep; 1984 Jan; 68(1):9-19. PubMed ID: 6362871
    [No Abstract]   [Full Text] [Related]  

  • 5. 3. Proposal for the National Cancer Institute Cancer Chemotherapy Program.
    Cancer Chemother Rep; 1966 Oct; 50(7):461-540. PubMed ID: 5919868
    [No Abstract]   [Full Text] [Related]  

  • 6. History of the Cancer Chemotherapy Program.
    Cancer Chemother Rep; 1966 Oct; 50(7):349-96. PubMed ID: 5331634
    [No Abstract]   [Full Text] [Related]  

  • 7. Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute.
    Carter SK; Slavik M
    Natl Cancer Inst Monogr; 1977 Mar; (45):101-21. PubMed ID: 73134
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrasting viewpoints on cancer drug development: the Wooldridge and Richardson reports.
    DeVita VT
    Cancer Treat Rep; 1984 Jan; 68(1):339-40. PubMed ID: 6692433
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer chemotherapy: new recruits.
    David P
    Nature; 1983 Aug 25-31; 304(5928):675. PubMed ID: 6888533
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer research program strategy and planning--the use of contracts for program implementation.
    Baker CG
    J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):651-69. PubMed ID: 328910
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer problems lead list for potential medical marijuana research studies.
    Smigel K
    J Natl Cancer Inst; 1997 Sep; 89(17):1255. PubMed ID: 9293912
    [No Abstract]   [Full Text] [Related]  

  • 13. The Cancer Chemotherapy Programs, 1965.
    Cancer Chemother Rep; 1966 Oct; 50(7):397-460. PubMed ID: 5921754
    [No Abstract]   [Full Text] [Related]  

  • 14. Collection and presentation of combination data.
    Mancher RR
    Cancer Chemother Rep 2; 1974 Mar; 4(1):167-80. PubMed ID: 4826496
    [No Abstract]   [Full Text] [Related]  

  • 15. The cooperative clinical research program of the National Cancer Institute.
    Foye LV
    Am J Roentgenol Radium Ther Nucl Med; 1970 Jan; 108(1):14-8. PubMed ID: 5410698
    [No Abstract]   [Full Text] [Related]  

  • 16. The NCI Developmental Therapeutics Program.
    Collins JM
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):271-3. PubMed ID: 16728938
    [No Abstract]   [Full Text] [Related]  

  • 17. The National Cancer Chemotherapy Program.
    Frei E
    Science; 1982 Aug; 217(4560):600-6. PubMed ID: 7046055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of cancer chemotherapy.
    Chabner BA
    Hosp Pract (Off Ed); 1985 Apr; 20(4):115-9, 123-7. PubMed ID: 3932415
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.